Qool Therapeutics Raises $8 Million for Targeted Temperature Management System
Device to treat multiple clinical conditions in vascular surgery, cardiac arrest and trauma gearing up for first-in-human studies
November 28, 2017
MENLO PARK, Calif.–(BUSINESS WIRE)–Qool Therapeutics, Inc., a company developing a novel non-invasive targeted temperature management system, has raised an $8 million Series A-1 round for clinical product development and to prepare for first-in-human studies. Read the full press release here.